Search

everythinglearnresearchcommunity

for

Search:↓

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

The contraceptive implant Implanon may be linked to hair loss, but the reported case of alopecia could be unrelated to the implant.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

Oral contraceptives with desogestrel and drospirenone improve PCOS symptoms.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Using LC-MS/MS for hormone measurement can prevent false high testosterone results and avoid unnecessary tests.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

New treatments targeting insulin, blood flow, and inflammation could improve hormone-related hair conditions with fewer side effects.

Mutations in the androgen receptor gene cause different levels of androgen insensitivity, making it hard to create simple tests for the condition.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Male rats grow hair faster than females, and certain hormones can slow or slightly increase hair growth, but not significantly beyond natural rates.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Anti-aging treatments like hair transplants, minoxidil, and finasteride effectively promote hair growth.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

Fetuin-A levels are higher in PCOS patients, suggesting it may play a role in the condition.

Environmental, chemical, mechanical, and personal health factors can all damage hair and contribute to hair loss or changes in hair quality.

Female pattern hair loss, common in women, can be treated with various methods like minoxidil, anti-androgen treatments, and light therapy, but early intervention and realistic expectations are crucial.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Male pattern baldness involves hormones and cell signals affecting hair growth.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Women with different PCOS types have similar fertility treatment results.

Plant compounds may help manage PCOS, endometriosis, and menstrual issues.